These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19276385)

  • 1. Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity.
    Rong Y; Belozerov VE; Tucker-Burden C; Chen G; Durden DL; Olson JJ; Van Meir EG; Mackman N; Brat DJ
    Cancer Res; 2009 Mar; 69(6):2540-9. PubMed ID: 19276385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic activation of wild-type epidermal growth factor receptor and loss of Cdkn2a cause mouse glioblastoma formation.
    Acquaviva J; Jun HJ; Lessard J; Ruiz R; Zhu H; Donovan M; Woolfenden S; Boskovitz A; Raval A; Bronson RT; Pfannl R; Whittaker CA; Housman DE; Charest A
    Cancer Res; 2011 Dec; 71(23):7198-206. PubMed ID: 21987724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of phosphatidylinositol 3-kinase signaling negates the growth advantage imparted by a mutant epidermal growth factor receptor on human glioblastoma cells.
    Klingler-Hoffmann M; Bukczynska P; Tiganis T
    Int J Cancer; 2003 Jun; 105(3):331-9. PubMed ID: 12704666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTX3 gene activation in EGF-induced head and neck cancer cell metastasis.
    Chang WC; Wu SL; Huang WC; Hsu JY; Chan SH; Wang JM; Tsai JP; Chen BK
    Oncotarget; 2015 Apr; 6(10):7741-57. PubMed ID: 25797258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will kinase inhibitors make it as glioblastoma drugs?
    Mellinghoff IK; Schultz N; Mischel PS; Cloughesy TF
    Curr Top Microbiol Immunol; 2012; 355():135-69. PubMed ID: 22015553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells.
    Li HF; Kim JS; Waldman T
    Radiat Oncol; 2009 Oct; 4():43. PubMed ID: 19828040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR wild type antagonizes EGFRvIII-mediated activation of Met in glioblastoma.
    Li L; Puliyappadamba VT; Chakraborty S; Rehman A; Vemireddy V; Saha D; Souza RF; Hatanpaa KJ; Koduru P; Burma S; Boothman DA; Habib AA
    Oncogene; 2015 Jan; 34(1):129-134. PubMed ID: 24362532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular Hyaluronic Acid Influences the Efficacy of EGFR Tyrosine Kinase Inhibitors in a Biomaterial Model of Glioblastoma.
    Pedron S; Hanselman JS; Schroeder MA; Sarkaria JN; Harley BAC
    Adv Healthc Mater; 2017 Nov; 6(21):. PubMed ID: 28766870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes.
    Huang K; Fang C; Yi K; Liu X; Qi H; Tan Y; Zhou J; Li Y; Liu M; Zhang Y; Yang J; Zhang J; Li M; Kang C
    Theranostics; 2018; 8(6):1540-1557. PubMed ID: 29556340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intron 1-Mediated Regulation of
    Jameson NM; Ma J; Benitez J; Izurieta A; Han JY; Mendez R; Parisian A; Furnari F
    Mol Cancer Res; 2019 Nov; 17(11):2208-2220. PubMed ID: 31444232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR/SRC/ERK-stabilized YTHDF2 promotes cholesterol dysregulation and invasive growth of glioblastoma.
    Fang R; Chen X; Zhang S; Shi H; Ye Y; Shi H; Zou Z; Li P; Guo Q; Ma L; He C; Huang S
    Nat Commun; 2021 Jan; 12(1):177. PubMed ID: 33420027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol 3-Kinase dependent upregulation of the epidermal growth factor receptor upon Flotillin-1 depletion in breast cancer cells.
    Kurrle N; Ockenga W; Meister M; Völlner F; Kühne S; John BA; Banning A; Tikkanen R
    BMC Cancer; 2013 Dec; 13():575. PubMed ID: 24304721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPA
    Valdés-Rives SA; Arcos-Montoya D; de la Fuente-Granada M; Zamora-Sánchez CJ; Arias-Romero LE; Villamar-Cruz O; Camacho-Arroyo I; Pérez-Tapia SM; González-Arenas A
    Cells; 2021 Apr; 10(4):. PubMed ID: 33916643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of EGFR, ERK-1,2 and AKT-1,2 Activity on Human Glioma Cell Growth.
    Alahverdi A; Arefian E; Soleimani M; Ai J; Yousefi-Ahmadipour A; Babaei A; Islam MS; Ebrahimi-Barough S
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3469-3475. PubMed ID: 33369441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen Receptor Activation in Glioblastoma Can Be Achieved by Ligand-Independent Signaling through EGFR-A Potential Therapeutic Target.
    Zalcman N; Gutreiman M; Shahar T; Weller M; Lavon I
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Invasion Factor ODZ1 Is Upregulated through an Epidermal Growth Factor Receptor-Induced Pathway in Primary Glioblastoma Cells.
    Velasquez C; Gutierrez O; Carcelen M; Fernandez-Luna JL
    Cells; 2024 Apr; 13(9):. PubMed ID: 38727302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acridine yellow G blocks glioblastoma growth via dual inhibition of epidermal growth factor receptor and protein kinase C kinases.
    Qi Q; He K; Yoo MH; Chan CB; Liu X; Zhang Z; Olson JJ; Xiao G; Wang L; Mao H; Fu H; Tao H; Ramalingam SS; Sun SY; Mischel PS; Ye K
    J Biol Chem; 2012 Feb; 287(9):6113-27. PubMed ID: 22215664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma.
    Walsh AM; Kapoor GS; Buonato JM; Mathew LK; Bi Y; Davuluri RV; Martinez-Lage M; Simon MC; O'Rourke DM; Lazzara MJ
    Mol Cancer Res; 2015 Aug; 13(8):1227-37. PubMed ID: 25934697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Proteomics Reveals Fundamental Regulatory Differences in Oncogenic HRAS and Isocitrate Dehydrogenase (IDH1) Driven Astrocytoma.
    Doll S; Urisman A; Oses-Prieto JA; Arnott D; Burlingame AL
    Mol Cell Proteomics; 2017 Jan; 16(1):39-56. PubMed ID: 27834733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotics possess anti-glioblastoma activity by disrupting lysosomal function and inhibiting oncogenic signaling by stabilizing PTEN.
    Jacob JR; Palanichamy K; Chakravarti A
    Cell Death Dis; 2024 Jun; 15(6):414. PubMed ID: 38871731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.